Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001079973-17-000249
Filing Date
2017-04-27
Accepted
2017-04-27 16:58:30
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A bioptix_10ka-123116.htm 10-K/A 287883
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 9068
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 9366
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 6461
  Complete submission text file 0001079973-17-000249.txt   314072
Mailing Address 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104
Business Address 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104 303-794-2000
Bioptix, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33675 | Film No.: 17790005
SIC: 2835 In Vitro & In Vivo Diagnostic Substances